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Quantitative or comparative proteome analysis was initially performed with 2-dimensional gel
electrophoresis with the inherent disadvantages of being biased towards certain proteins and
being labor intensive. Alternative mass spectrometry-based approaches in conjunction with
gel-free protein/peptide separation have been developed in recent years using various stable
isotope labeling techniques. Common to all these techniques is the incorporation, biosyntheti-
cally or chemically, of a labeling moiety having either a natural isotope distribution of
hydrogen, carbon, oxygen, or nitrogen (light form) or being enriched with heavy isotopes like
deuterium, 13C, 18O, or 15N, respectively. By mixing equal amounts of a control sample
possessing for instance the light form of the label with a heavy-labeled case sample,
differentially labeled peptides are detected by mass spectrometric methods and their intensi-
ties serve as a means for direct relative protein quantification. While each of the different
labeling methods has its advantages and disadvantages, the endoprotease 16O-to-18O catalyzed
oxygen exchange at the C-terminal carboxylic acid is extremely promising because of the
specificity assured by the enzymatic reaction and the labeling of essentially every protease-
derived peptide. We show here that this methodology is applicable to complex biological
samples such as a subfraction of human plasma. Furthermore, despite the relatively small mass
difference of 4 Da between the two labeled forms, corresponding to the exchange of two
oxygen atoms by two 18O isotopes, it is possible to quantify differentially labeled proteins on
an ion trap mass spectrometer with a mass resolution of about 2000 in automated data
dependent LC-MS/MS acquisition mode. Post column sample deposition on a MALDI target
parallel to on-line ESI-MS/MS enables the analysis of the same compounds by means of ESI-
and MALDI-MS/MS. This has the potential to increase the confidence in the quantification
results as well as to increase the sequence coverage of potentially interesting proteins by
complementary peptide ionization techniques. Additionally the paired y-ion signals in tandem
mass spectra of 16O/18O-labeled peptide pairs provide a means to confirm automatic protein
identification results or even to assist de novo sequencing of yet unknown proteins. (J Am
Soc Mass Spectrom 2003, 14, 704–718) © 2003 American Society for Mass Spectrometry
Genome sequencing projects have led to the pub-lication of an increasing number of genomesequence databases in recent years. These ge-
nome sequence databases are the basis for the auto-
mated identification of proteins by mass spectrometry
and has led to an enormous boost in the area of protein
discovery, protein-protein interaction and protein char-
acterization sciences. The term “proteomics” was ini-
tially used in 1994 at the Siena meeting for protein
separation based on 2-dimensional gel electrophoresis.
Today the field of proteomics covers essentially all of
the above described efforts. To understand complex
cellular dynamics, powerful methods for quantification
of the messenger ribonucleic acid (mRNA) synthesis
have been developed [1–3]. Although these methods are
very sensitive, mRNA expression levels do not neces-
sarily reflect changes in the concentration of specific
functional proteins in cells [4]. This is especially true if
the final step for the synthesis of functional proteins
encompasses post-translational modifications (PTMs).
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Hence, the analysis of the protein content (proteome)
provides more accurate information about biological
systems and pathways because the measurement is
directly focused on proteins, the actual biological effec-
tor molecules.
In the case of blood plasma, proteome analysis is the
only means to detect perturbation-related changes in its
protein content because essentially every cell of an
organism releases proteins into the plasma, hence there
is no unique source of mRNA. Plasma proteins chang-
ing in their relative concentration between a control and
a perturbed state can potentially serve as biomarkers, or
may represent drug targets or protein therapeutics for a
certain disease. Determination of protein concentration
changes is therefore fundamental for the understanding
of a biological system as well as for pharmaceutical
research. There are currently various options for rela-
tive quantification of proteins in biological samples.
Differential stable isotope labeling of proteins in com-
parative samples is a commonly used method for sub-
sequent quantitative analysis by mass spectrometry [5].
There are several approaches available for incorpo-
rating the stable isotope label, and the most appropriate
one depends on sample source and type. When pro-
teome samples are of human origin, such as human
plasma and serum, it is not practical to label proteins
metabolically [6–8]. Post-biosynthesis/bioprocess la-
beling, in contrast to metabolic labeling, is more versa-
tile. Chemical labeling by alkylation, esterification, or
acylation [9–11] and endoprotease catalyzed labeling
with 18O at the C-terminus of peptides [12–14], present
examples of post-biosynthesis labeling.
In analyzing systems as complicated as entire pro-
teomes, by-products of labeling reactions need to be
kept to a minimum in order to reduce the workload for
data acquisition and analysis. Additionally, in order to
obtain the maximal proteome coverage in a compara-
tive protein quantification experiment, it is important to
generate as many labeled peptides as possible.
Enzymatic labeling of proteins/peptides has been
proposed to compare protein quantities in two counter-
part proteomes mainly because, compared to chemical
labeling methods, the enzymatic labeling is highly
specific and is almost universally applicable [15].
Through its ability to universally label almost all the
carboxyl termini, enzymatic labeling is an ideal choice
to quantitatively study mixtures of low molecular
weight proteins. These proteins may not contain many
or any cysteine residues for example, a common target
for chemical labeling reactions like ICAT [9]. Besides,
when compared with large proteins, small proteins
generate fewer peptides upon digestion, especially in-
formation-rich peptides (peptides that are useful to
identify their precursor proteins unambiguously). In
addition, by targeting all endoprotease-specific pep-
tides, the enzymatic approach will label post-transla-
tionally modified peptides that go otherwise undetec-
ted with ICAT if they do not contain a cysteine residue.
Furthermore not all the peptides generated can be
ionized for mass spectrometric analysis via electrospray
ionization or matrix-assisted laser desorption/ioniza-
tion process, again limiting the usefulness for quantifi-
cation of small proteins by labeling strategies which
target only specific residues. Finally, isotopic 18O label-
ing does not alter the physical properties of peptides,
such that they ionize exactly as their unlabeled coun-
terparts, and no shift in the chromatographic behavior
has been reported.
We show here that trypsin-catalyzed 16O-to-18O ex-
change is a valid differential isotope-coding technology
for comparative proteomics using mass spectrometry-
based analysis of complex protein mixtures like a low
molecular weight protein subfraction of human blood
plasma. Ion trap and MALDI-TOF mass spectrometers
are probably the most abundant instruments in protein
mass spectrometry laboratories world-wide. We dem-
onstrate that 16O/18O-labeled peptide pairs, with a 4 Da
mass differential, can successfully be quantified on
relatively low resolving ion trap or higher resolving
TOF mass spectrometers.
Experimental Methods
All protein/peptide standards were purchased either
from Bachem (Bubendorf, Switzerland) or Sigma
(Buchs, Switzerland). All chemicals were purchased
from either Fluka/Riedel de Haen/Sigma/Aldrich
(Buchs, Switzerland), or Merck (Dietikon, Switzerland),
and were of the highest quality available and used
without any further purification. Anhydrous dimethyl
sulfoxide (DMSO) and HPLC grade acetonitrile
(MeCN) were from Fluka/Riedel de Haen (Buchs, Swit-
zerland), acetic acid (HAc) 100% from Amman-Technik
AG (Koelliken, Switzerland), trifluoroacetic acid (TFA)
and heptafluorobutyric acid (HFBA) from Pierce (Soco-
chim SA, Lausanne, Switzerland), fused silica capillar-
ies from Polymicro Technologies Inc. (MSP Friedli &
Co, Ko¨niz, Switzerland), PLRPS column from Ercatech
AG (Bern, Switzerland), and nanobore reverse phase
(RP) liquid chromatography (LC) columns from GROM
GmbH (Rottenburg-Hailfingen, Germany). Water was
in-house purified and desalted by reverse osmosis and
a Milli-Q system (Millipore, Switzerland). -Cyano-4-
hydroxycinnaminic acid (HCCA) was purchased from
Bruker Daltonics (Bremen, Germany).
Trypsin Catalyzed 16O-to-18O Oxygen Exchange
Proteins were digested with modified porcine trypsin
from Promega (Catalys, Wallisellen, Switzerland) in 20
mM Tris/HCl pH 8.0 buffer at a substrate/protease
ratio of 50:1 (wt/wt). Peptides were dried completely in
a speedvac from Savant (Fisher Scientific, Wohlen,
Switzerland). The dried peptides were resuspended in
anhydrous DMSO at a concentration of 25 mg/ml. This
solution was further diluted using normal water or
95% enriched 18O-water (Isotec/Campro Scientific,
Berlin, Germany) and stock solutions of 5 M NaCl, 5 M
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CaCl2, and 1 mg/ml trypsin made up in either normal
water or 95% enriched 18O-water. The final composi-
tion for the oxygen exchange reaction was 2.5 mg/ml
peptide, 20 mM Tris/HCl pH 8.0, 50 mM NaCl, 50 mM
CaCl2, and trypsin at a substrate/protease ratio of 20:1
(wt/wt). This solution was incubated overnight at
30 °C. Samples were subsequently stored at 30 °C and
mixed just prior to further chromatography and/or
mass spectrometric analysis.
DMSO is as efficient in resuspending peptides as
formic acid. In contrast to formic acid and its salts, the
presence of 10% (vol/vol) DMSO increases the apparent
trypsin activity compared to water-based buffer alone
as measured with a commonly used kinetic trypsin
activity assay using N-benzoyl-L-arginine ethyl ester
as substrate (results not shown). In addition, we have
not detected any problems on chromatographic separa-
tions of samples containing residual traces of DMSO. It
has recently been reported that the addition of 10%
DMSO to reverse phase chromatography solvents can
even improve the detection of hydrophobic peptides
[16]. DMSO is known for its tendency to oxidize pep-
tides, but this can be taken into account during peptide
identification searches by allowing for oxidation as a
variable modification.
Preparation of a 16O/18O-Labeled Complex
Standard Protein Mixture Digest
Ten commercially available human proteins (total of
260 nmole) were dissolved in 3 ml 80:20 (vol/vol) of 20
mM Tris/HCl pH 8.0, 8 M urea/DMSO. The protein
composition was as follows, with the SWISS-PROT
accession number given in parenthesis: Atrial natri-
uretic factor (P01160)/-endorphin (P01189)/galanin
(P22466)/calcitonin (P01258)/growth hormone-releas-
ing factor (P01286)/pancreatic polypeptide (P01298)/
peptide YY (P10082)/gastrin-releasing peptide
(P07492)/-lactalbumin (P00709)/apolipoprotein A-II
(P02652), 4:4:4:4:2:2:2:2:1:1 (molar ratio). Two equal por-
tions of 1.4 ml of this protein stock solution were
reduced, alkylated, digested and 16O/18O-labeled in
parallel. Briefly, proteins were reduced for 3 h at 37 °C
by the addition of 33 l of 200 mM dithioerythritol
(DTE) in 20 mM Tris/HCl pH 8.0, followed immedi-
ately by addition of 200 l of 100 mM iodoacetamide in
20 mM Tris/HCl pH 8.0 for alkylation at 37 °C in the
dark. After 0.5 h, 75l of 2-mercaptoethanol was added
to the solution. The proteins were then digested over-
night at 30 °C with porcine trypsin at a substrate/
enzyme ratio of 50:1, after dilution to a final volume of
10 ml in 20 mM Tris/HCl pH 8.0, 50 mM NaCl, 50 mM
CaCl2. The pH was lowered to 3 using a minimal
volume of 10% (vol/vol) TFA. Both samples were
desalted using a SepPak C-18 light cartridge (Waters,
Rupperswil, Switzerland) according to the manufactur-
ers recommendations. Peptides were eluted from the
SepPak resin with 70% (vol/vol) methanol. Both pep-
tide solutions were dried completely by vacuum cen-
trifugation and were subsequently labeled with either
16O or 18O as described above. For LC-MS/MS analysis
of 16O/18O-labeled mixtures, approximately 5 pmol/l
total peptides at the desired 16O/18O-ratio were pre-
pared in 1% (vol/vol) TFA, loading 0.5 l on the
nanobore column of the ESI-QTOF system as described
below.
Preparation of 16O/18O-Labeled Horse
Apomyoglobin Digest
To 50 nmole of lyophilized apomyoglobin powder in a
vial, as delivered by Sigma, 90 l of 20 mM Tris/HCl
pH 8.0 and 10 l of 1 mg/ml porcine trypsin were
added without shaking and incubated for 2 h at 37 °C.
A volume of 785 l of 20 mM Tris/HCl pH 8.0 together
with 100 l MeCN and 5 l 2-mercaptoethanol were
added and mixed gently. Digestion of the apomyoglo-
bin was completed by further addition of 10l of 1
mg/ml porcine trypsin and incubation for 16 h at 37 °C.
The final digest was aliquoted and stored until further
use at 30 °C. The isotopic labeling of tryptic apomyo-
globin was performed as described above.
Preparation of a Human Plasma Low Molecular
Weight Protein Subfraction
Blood was obtained using standard veinous puncture
procedures in a medical centre setting after informed
written consent of donors. Plasma was prepared by
centrifugation and removal of white cells on filters by
standard techniques. Protease inhibitor (Complete,
Roche) was added according to the manufacturer’s
instructions and mixed gently to ensure dissolution.
Plasma samples were then frozen and stored at 80 °C.
Plasma was thawed, 10 ml were filtered through a 0.45
m filter and applied to a proprietary column combi-
nation (36 ml bed volume) that adsorbs serum albumin
and immunoglobulins removing close to 100% of these
highly abundant plasma proteins as assessed by 2-D gel
electrophoresis. The flow-through fraction was applied
to gel filtration chromatography on a 1.6 litre bed
volume column that was equilibrated and percolated
with a buffer containing 8 M urea, monitoring at 280
nm. Low pressure chromatography equipment (Akta
Purifier) was from Amersham Bioscience (Uppsala,
Sweden). After elution of the larger proteins (as moni-
tored in prior experiments by gel electrophoresis) the
equivalent of one column volume of the effluent was
diverted to a column of reversed phase medium that
adsorbed the low molecular weight proteins and pep-
tides (ca. Mr 20–25 kDa cutoff). After washing, the
capture column was developed with two column vol-
umes of a 0–80% MeCN gradient containing 0.2%
(vol/vol) TFA. Protein content in the collected eluate
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was determined by analytical size exclusion HPLC
using BSA as a standard, and this fraction was stored at
30 °C until further use.
Digestion, 16O/18O labeling, and SCX
Fractionation of a Low Molecular Weight Protein
Human Plasma Subfraction
A human plasma subfraction containing low molecular
weight proteins in a volume of 3 ml at a protein
concentration of 0.76 mg/ml, prepared as described
above, was diluted with 3 ml of 20 mM Tris/HCl pH
8.0, 8 M urea. Proteins were reduced by the addition of
10 mM DTE at 37 °C for 1 h, followed by alkylation with
40 mM iodoacetamide at 37 °C for 30 min in the dark.
Immediately after alkylation the sample was diluted 1:9
in 4 M urea and acidified to pH 3 by addition of 10%
(vol/vol) TFA. Proteins were loaded on a reverse phase
PLRPS column with a bed volume of 0.3 ml. After
extensive washing of the column with 0.2% (vol/vol)
TFA in water, proteins were eluted by a two column
volume gradient of 0–80% MeCN containing 0.2% TFA.
The protein solution was frozen in liquid nitrogen and
lyophilized. The dry protein powder was digested with
trypsin at an enzyme/substrate ratio of 1:50 as de-
scribed for apomyoglobin. The sample was then split
into two equal portions followed by C-terminal 16O-to-
16O oxygen exchange with one portion and 16O-to-18O
oxygen exchange with the other as described above.
The final reaction volume of each sample was 460 l.
After the labeling procedure, 4.3 l of 16O-labeled
apomyoglobin digest (200 pmol) were added to the
16O-labeled plasma peptide sample and 2.15 l (100
pmol) of 18O-labeled apomyoglobin digest was added
to the 18O-labeled plasma peptide sample. Aliquots of
175l from both samples were mixed together and
diluted in 700 l 0.1% (vol/vol) formic acid containing
20% (vol/vol) MeCN resulting in a theoretical 16O-to-
18O-ratio of 2:1 and 1:1 for apomyoglobin and plasma
protein peptides respectively. 1 ml of this mixture was
loaded on a strong cation exchange (SCX) column
(PL-SCX 8um 1000A, 50  2.1 mm; Polymer labs)
equilibrated with 0.1% (vol/vol) formic acid in 20%
(vol/vol) MeCN. The column was developed with a
step gradient beginning with 2.5% and followed by
0.5% steps (3 column volumes each) of a 1 M ammo-
nium acetate buffer in 0.3% (vol/vol) formic acid/20%
(vol/vol) MeCN at a flow rate of 200 l/min. Chroma-
tography was performed on an Alliance 2795 separation
module equipped with a photodiode array detector and
a fraction collector (Waters, Millford, MA). The chro-
matography was monitored at 280 nm. Peptides in the
eluate were collected according to the salt steps in 1.5
ml polypropylene tubes. Fractions were dried in a
speedvac and peptides redissolved in 20% formic acid
prior to LC-MS/MS analysis.
LC-ESI/MALDI-MS/MS Analysis of 16O/18O-
Labeled Peptides
LC-ESI/MALDI. The ion trap system consisted of an
Esquire3000plus (Bruker Daltonics, Bremen, Germany)
equipped with a standard electrospray (ESI) source and
coupled to an Alliance 2795 separation module deliver-
ing a flow rate of 3 l/min with an in-house built flow
splitter. Reverse phase liquid chromatography was per-
formed on a nanobore GROM-SIL C8 column, 5 m, 0.1
 100 mm, using a bi-phasic gradient of 0–10% solvent
B in 2 min, followed by 10–40% solvent B in 30 min.
Solvent A consisted of 5% (vol/vol) MeCN in 0.4%
(vol/vol) HAc, 0.005% (vol/vol) HFBA; solvent B was
95% (vol/vol) MeCN containing 0.4% HAc. The post
column flow was split with a micro-T (Valco-Vici,
Schenkon, Switzerland) diverting the column eluate by
a ratio of 2:1 to the ESI source and a LC-MALDI
interface, respectively.
The LC-MALDI interface was achieved by pulling a
75 m inner diameter fused silica capillary through one
of the needles of a MAP II/8 preparation robot (Bruker
Daltonik, Bremen, Germany). Sample deposition on a
prestructured sample support (384 anchor target,
Bruker Daltonik, Bremen, Germany) was performed by
moving the steel needle with the fixed capillary in
z-direction towards the sample support. Upon contact
with the target, the eluate droplet of 250 nl forming at
the tip of the capillary within the 15 s sampling time
was dispensed to the 600 m diameter matrix precoated
hydrophilic anchor. All movements of the robot and the
synchronization with the HPLC were controlled by an
Excel VBA script within the MAP-control software
supplied by the manufacturer. The matrix precoating of
the target was made by placing a small volume of
HCCA matrix solution [1 g/l in Acetone/TFA (0.1%)
97:3 vol/vol] on each of the individual anchors by the
help of a small pipet tip (GELoader, Eppendorf) [17]. A
consecutive addition of 1 l of a diluted matrix solution
(0.1 g/l HCCA in ethanol/acetone/TFA (0.1% vol/vol)
at a volume ratio of 60:30:10) was applied by another
MAPII/8 robot.
Ion trap MS/MS. The ion trap (ESI-IT) was tuned to
allow the isolation of the entire 16O/18O-isotopic enve-
lope of doubly and higher charged peptides, irrespec-
tive of which of the labeled forms was chosen as the
precursor for MS/MS as shown in Figure 1 (isolation
width of 5 m/z, isolation coarse high of 150, isolation
fine high of 10, and isolation fine low of 70). Otherwise
the ion trap was operated in data-dependent MS to
MS/MS switching mode using two precursors detected
in the 350–1600 m/z unit window and excluding singly
charged ions. The duty cycle for such a data dependent
MS/MS cycle was in the order of 8 to 9 s depending on
the precursor ion intensity. This dependency is due to
the fact that this instrument regulates ion accumulation
times in the trap based on detected ions. The charge
state of precursor ions is detected instantaneously dur-
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ing acquisition by a Bruker proprietary algorithm. Pre-
cursors were excluded for one min after one MS/MS
acquisition and the scan range was kept between 100 to
1600 m/z.
MALDI-TOF MS. MALDI-TOF spectra of positively
charged ions were recorded in reflector mode on either
a Bruker ReflexIII or a Bruker Ultraflex MALDI-TOF
mass spectrometer (Bremen, Germany), both equipped
with a Scout 384 ion source. Both instruments were
operated under delayed ion extraction conditions and
optimized to achieve a mass resolution of 3000–15000
(up to 20000 for the Ultraflex) over the whole mass
range of interest (600–4000 Da), using a total accelera-
tion voltage of 25 kV. A deflection of matrix ions up to
600 Da was furthermore applied to prevent detector
saturation. Calibration was performed by external cali-
bration over a wide mass range using bradykinin,
angiotensin II, substance P, bombesin and ACTH clip
18-39.
MALDI-TOF/TOF MS/MS. MALDI-TOF/TOF MS/
MS was carried out using the MALDI post-source-
decay (PSD) in combination with the LIFT-cell TOF/
TOF set-up of the Ultraflex mass spectrometer [18, 19].
Briefly, after the first TOF stage with an acceleration
voltage of 8 kV, parent and metastable fragment ions
induced by the PSD process were selected simulta-
neously by a timed ion gate. The ion package was then
lifted in the timed LIFT-cell by a 19 KV potential. Data
dependent single-scan MS/MS experiments were car-
ried out in an automated fashion with the FlexControl
1.2 software that applies several filters for parent selec-
tion, e.g., signal intensity, signal-to-noise ratio or reso-
lution. The calibration of the MS/MS spectra is per-
formed automatically by the XMASS data processing
software, using mass dependent higher order machine
calibration curves in combination with the parent ion
lock mass.
ESI-QTOF MS/MS. The Q-Tof micro was equipped
with a Micromass CapLC with autosampler (Micro-
mass, UK) using a ten port zero dead volume valve
(Valco-Vici) enabling fast sample loading on a pre-
column (Opti-Guard 1mm, Symmetrie C18, Optimize
Technologies Inc., OR) at a flow rate of 15 l/min
isocratically with solvent A delivered by auxiliary
pump C. The composition of solvents A and B was 0.1%
(vol/vol) formic acid in 3% (vol/vol) MeCN or 95%
(vol/vol) MeCN, respectively. After washing of the
pre-column, the ten-port valve was switched allowing
delivery of a tri-phasic MeCN gradient at 300–400
nl/min onto the analytical column (GROM Ruby C8, 2
m, 0.1  100 mm) by back-flushing the pre-column.
The three phases of the gradient were from 0 to 25% B
in 2 min, then 5 min isocratically at 25% B, followed by
25 to 40% B during 30 min. The Q-TOF was operated in
DDA mode using a 1-s MS survey scan followed by 2-s
scans, each on three different precursor ions. CID
spectrum acquisition was allowed for up to a total of
12 s on each precursor ion or stopped when the signal
intensity fell below three counts per s respectively,
before a new MS to MS/MS cycle was started. This set
of parameters allows for acquisition of good quality
MS/MS spectra of low intensity ions but can increase
the duty cycle of the instrument to approximately 40 s
in case of three intense precursors present. Tapered
fused silica capillaries with a 10 m aperture (PicoTip,
New Objectives, Woburn, MA) served as spraying
emittors. Precursors were excluded from any further
MS/MS experiment for one min and singly charged
ions were excluded as precursors for MS/MS.
Figure 1. Tuning of ESI-IT for optimal isolation efficiency of the
entire isotope cluster of 16O/18O-labeled peptide ions. A horse
apomyoglobin digest labeled with 16O- or 18O-water, respectively,
was mixed at a theoretical ratio of 1:1 in 1% acetic acid/MeCN 1:1
at 1 pmol/l concentration. This solution was delivered to the
ESI-IT using a syringe pump at a flow rate of 2 l/min. The
doubly charged tryptic peptide ions LFTGHPETLEK (m/z 
636.34), HGTVVLTALGGILK (m/z  689.93), VEADIAGHGQEV-
LIR (m/z 803.93), and GHHEAELKPLAQSHATK (m/z 927.49),
respectively were isolated in the ion trap with the isolation
parameters set as described in the Experimental Methods section.
Isolation was done either on the I0 (left panel) or the I4 isotope
(right panel) resulting in mean 18O/16O-ratios of 0.94  0.17 and
1.13  0.31. The small black diamonds denote the isolated target
mass.
708 HELLER ET AL. J Am Soc Mass Spectrom 2003, 14, 704–718
Results and Discussion
Evaluation of Relative Protein Quantification by
18O Labeling
It has been shown that the catalysis of the C-terminal
18O labeling of peptides can be dissected from the actual
proteolysis of proteins by endoproteases like trypsin
[15, 20, 21]. During this process, two oxygens are
exchanged by trypsin into the -carboxyl group of
peptides C-terminally ending with a lysine or arginine
residue. This is because tryptic peptides continue to
interact with trypsin by forming covalent intermediates
with repeated binding/hydrolyses cycles. In order to
assess whether this technique allows for a proteome-
wide protein quantification, first tests were performed
with a mixture of ten standard proteins labeled differ-
entially with either 16O or 18O, ranging in Mr from 2184
to 16225 Da, mixed together at various concentrations
and analysed by nanoLC-MS on an ESI-QTOF mass
spectrometer (see Experimental Methods). Initially a
two-fold change in protein concentration was chosen to
evaluate the lower quantification limit of the 18O label-
ing method.
For this, either the 16O pool or the 18O pool was set at
the higher concentration. For quantification, the ratios
of the first mono-isotopic peaks I0/I4 (I0 and I4 stand for
the first isotopic peak of the 16O- and 18O-labeled
peptides, respectively, recalling that two oxygens are
incorporated) and the second isotopic peaks, I1/I5, were
calculated. While the statistical averages were basically
the same for a given sample analyzed, the ratio I1/I5
better represents the relative quantity for larger pep-
tides. The switch from I0/I4 to I1/I5 should be applied in
the mass range of 1500 to 1800 Da where the second
isotopic peak becomes more intense than the first one
and the intensity contribution of the fifth isotope of the
16O-labeled peptide to the intensity of I4 becomes sig-
nificant. A total of 17 precursor peptides, present as
singly, doubly, or triply charged ions, were considered
from the ion chromatography of TOF MS on the ESI-
QTOF instrument. The ratios of a theoretical 1:2 16O/
18O mixture ranged from 0.41 to 0.56. The average was
0.50  0.05 (panel a in Figure 2). Duplicating the
experiment by mixing a freshly prepared sample gave
ratios in the range of 0.49 to 0.71 and an average ratio of
0.61  0.06. The difference between the two averages is
likely due to errors during mixing and/or differential
losses during desalting on the SepPak cartridges rather
than the labeling procedure itself. A sample set with the
16O/18O reversed to 2:1 resulted in a mean ratio of 2.2
0.2 for the same 17 peptides (Figure 2, panel b). In these
three sample sets the standard deviations were always
10% and the extreme ratios in each sample set differed
less than 50% from the theoretical ratio values of 0.5 or
2.0 respectively. It can therefore be concluded that the
18O labeling method enables quantitative proteomics
with a confidence in changes of protein concentrations
as low as 2-fold.
The high-end limit of relative quantification is deter-
mined by the mass spectrometer, acquisition parameter
settings, and also by the complexity of the sample. The
higher the signal-to-noise ratio (S/N), the higher the
dynamic range of the method will be. With standard
parameter settings on the QTOF, 10- to 20-fold differ-
ences were detected by averaging all MS spectra ac-
quired during the chromatographic elution of each
individual peptide pair. A sample set consisting of a
1:10 16O/18O mixture of the same protein digest mixture
as described above resulted in a mean ratio of 0.13 
0.02, with a range of values between 0.11 and 0.20. With
this and other results (not shown), we concluded that it
is possible to measure semi-quantitatively 10- to 20-fold
differences with 18O-labeled samples on a time-of-flight
instrument.
In order to improve the data quality on samples with
higher differences, longer acquisition times were re-
quired to increase the S/N ratios. However, the need to
perform LC separation of complex samples on-line to
ESI-MS imposes a limit on increased acquisition times
due to chromatographic peak width and the need to
obtain high sequence coverage of the peptides present
in the sample. Today, ion trap mass spectrometers are
cheaper and have faster cycle times in automatic, data-
dependent MS to MS/MS acquisitions than a quadru-
pole/time-of-flight instrument (8 to 9 s for ESI-IT com-
pared to up to 24 s for ESI-QTOF with 2 precursors, as
described in Experimental Methods section). An alter-
native is MALDI-TOF-MS as the samples are static.
With MALDI, it can be envisaged to acquire MS spectra
until the entire sample is ablated from the sample target
plate. Compared to direct MALDI-MS analysis of a
digest, coupling an LC separation of peptide mixtures
with fraction collection directly on MALDI plates (LC-
MALDI) drastically reduces sample complexity result-
ing in an increase in peptide concentration from a
chromatographic peak, and decreased ion suppression
by contaminants. All these effects add up to an increase
in the S/N. For these reasons, we evaluated the possi-
bility to use an ion trap instrument for quantification of
18O-labeled samples with combined on-line LC-ESI and
LC-MALDI.
Protein Quantification by LC-ESI-MS/MS on Ion
Trap
Peptide pairs C-terminally labeled by 16O or 18O differ
only by 4 Da in mass. Under electrospray ionization
multiply charged peptide ions are formed which are
detected as doubly, triply, or quadruply charged spe-
cies. The resulting differences in m/z units are therefore
of 2, 1.33, and 1 units, respectively, between the 16O-
and the 18O-labeled version. Due to the close spacing of
the isotopes it was always considered to be necessary to
use a mass spectrometer with high resolution, e.g.,
MALDI-TOF or ESI-QTOF. Use of ion trap MS was
therefore suggested to be difficult [15]. Recently, man-
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Figure 2. Proof of concept for the quantification of differential protein expression with C-terminally
18O-isotope labeled peptides. Ten standard proteins were digested, the mixture split in half and
subsequently labeled by enzyme catalyzed oxygen exchange at the C-terminal Lys and Arg residues
of the tryptic peptides either with 16O- or 18O-water. The two samples were mixed at ratios 1:2 or 2:1
and analyzed by LC-nanoESI-MS on a QTOF instrument. A total of 17 representative peptides, as 1,
2, and 3 ions, were chosen for the calculation of the peak intensity ratios of the 16O- and
18O-labeled peptides. ESI-QTOF MS spectra of these ions are shown in panel A for the 1:2 mixture and
in panel B for the 2:1 mixture, respectively. The average 16O/18O-ratio in case of the 1:2 mixture was
calculated as 0.50  0.05 and 2.2  0.2 for the 2:1 mixture, respectively.
710 HELLER ET AL. J Am Soc Mass Spectrom 2003, 14, 704–718
ufacturers of ion trap instruments made some major
improvements to the performance of their instruments.
For instance, the Bruker Esquire3000plus has improved
ion optics coupled with a higher sensitivity compared
to its predecessor. In addition, the MS instrument can
be run in the so-called “enhanced mode” with 20
acquired data points per m/z unit allowing for isotopic
resolution of triply, and under ideal conditions, even
quadruply charged ions. We were therefore interested
to test this instrument for quantification of 18O-labeled
peptides. A horse apomyoglobin digest was labeled
with 18O and mixed with 16O-labeled peptides in the
ratios of 1:1, 1:5, 1:10, 1:20, 5:1, 10:1, and 20:1. An aliquot
corresponding to 100 fmol of the lower abundant iso-
tope of each mixture was analyzed by LC-ESI-MS/MS
using the tuning parameters described under Experi-
mental Methods.
The LC-MS/MS data provides three possibilities for
ratio calculation. First, there is the MS scan on the intact
peptide precursor or alternatively a summed MS spec-
trum over the entire chromatographic peak of a precur-
sor. The latter gave increased S/N ratios, hence more
accurate 18O/16O-ratios and should definitely be ap-
plied when dealing with higher concentration differ-
ences, e.g. exceeding 10-fold limits.
Second, 18O/16O-ratios could also be calculated from
MS/MS spectra [22] because y-ions retain the C-termi-
nally labeled lysine or arginine residues. However,
special care needs to be taken when using these ions. A
peptide can fragment in many ways resulting in differ-
ent types of ions. Therefore chances are high that the
signal of a y-ion isotope can be disturbed by the
presence of an underlying fragment ion of the b, a, or
c-series. An example is the y4-ion of monoisotopic mass
500.356 from the apomyoglobin peptide VEADIAGH-
GQEVLIR that is almost isobaric with the a5-ion at
500.272. Although the 18O/16O-labeled pair of the y4-ion
was detected in the ESI-MS/MS spectra on the ion trap
as well as in the MALDI PSD-MS/MS spectra, the
18O/16O-ratios were far from ratios calculated on other
y-ions (not shown). Another observation was that the
calculated 18O/16O-ratios of low mass y-ion pairs dif-
fered in most cases considerably from the ones calcu-
lated in the higher mass range of the MS/MS spectra
(700–1500 m/z units). This effect could be explained by
decreased peak intensities, thus reduced S/N, at the
lower end of the mass range in ion trap generated
MS/MS spectra.
Third, extracted ion chromatograms (EIC) of the pair
of 18O- and 16O-labeled peptides could be used to
compare the area under the chromatographic peaks.
This approach was initially demonstrated for quantifi-
cation of ICAT-labeled samples [9]. The mass units of
the extracted ion signals need to be chosen with a very
narrow tolerance window (0.2 m/z) in order to prevent
contribution of the I2 to the
16O or 18O signal.
From the summarized results on apomyoglobin pep-
tides presented in Table 1, several trends can be ex-
tracted. The observed mean ratios seemed to be biased
in favor of the less abundant isotope regardless of
whether this was the 16O- or 18O-labeled peptide. This
observation corresponded with other data acquired on
Table 1. Relative 18O/16O-ratio quantification of different apomyoglobin mixtures using precursor ion intensities of MS scans, CID
y-ion fragment intensities, and extracted ion chromatogram (EIC) peak areas from ion trap LC-ESI-MS/MS acquisition data
18O/16O
expected MS signal
Number of
ionsa
18O/16O observed
(mean  SD)
R.D.
(%)
Relative errorb
(%)
1 Precursor ion 6 1.06  0.26 24.5 6
y-Ions 4 1.06  0.60 56.6 6
EIC 6 1.35  0.65 48.1 35
5 Precursor ion 7 4.21  1.18 28.0 16
y-Ions 17 4.39  0.50 11.4 12
EIC 6 8.81  6.76 76.7 76
0.2 Precursor ion 7 0.28  0.15 53.6 29
y-Ions 20 0.27  0.08 29.6 26
EIC 6 0.65  0.59 90.8 69
10 Precursor ion 7 9.13  3.76 41.2 9
y-Ions 17 7.98  2.82 35.3 20
EIC 6 8.81  7.18 81.5 12
0.1 Precursor ion 6 0.16  0.07 43.8 38
y-Ions 17 0.25  0.09 36.0 60
EIC 5 0.15  0.11 44.0 33
20 Precursor ion 7 15.10  7.46 49.4 25
y-Ions 19 14.32  16.74 116.9 28
EIC 6 18.82  8.21 43.6 6
0.05 Precursor ion 7 0.14  0.15 107.1 64
y-Ions 15 0.13  0.08 61.5 62
EIC 5 0.16  0.11 68.8 69
aNumber of ions where the pair of 18O- and 16O-labeled peptides was clearly detected. For precursor ion calculations only the more intense signal
between a 2 or 3 ion signal was included.
bFor relative error calculation, the intensity of the higher abundant isotopic peptide form was divided by the intensity of the less concentrated form.
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ESI-QTOF or MALDI-TOF instruments using the apo-
myoglobin test sample (see also Tables 2 and 3). There
are several reasons behind the observed bias, based on
calculations using I4/I0 and I5/I1 ratios. Here we ex-
tracted intensity values directly from the raw data,
consequently the first reason is the artificial contribu-
tion of the background chemical and electronic noise in
mass spectra that increases intensities of weak peaks.
Indeed subtraction of the background signals by an
in-house developed peak detection algorithm for
MALDI-TOF mass spectra could diminish this kind of
bias (not shown). Second, the residual 5% of 16O in the
18O-water theoretically increases I0 intensities by 0.25%
relative to the monoisotopic peak of the 18O-labeled
peptide. In the same manner I2 intensities are increased
by 9.5%. This in turn decreases the intensities of I4 and
I5 and as such can have negative effects in detecting
relative differences at higher ratios [23]. The use of
purer 18O-water will decrease these contributions.
Other factors contributing to the observed bias include
incomplete 18O incorporation, slow 18O-to-16O back
exchange and 13C contributions to the different isotopic
peak intensities. More sophisticated ratio calculations
can be applied to correct for the bias [13]. However this
bias does not prevent the 18O labeling method from
detecting protein concentration changes as low as 2-fold
using the simple I4/I0 and I5/I1 ratio calculations.
It is also apparent with 18O/16O mixtures of up to 1:5
ratios that the comparison with EIC traces resulted in
relative errors that were greater compared to precursor
ion MS and fragment ion MS/MS scans. As explained
above, due to residual 5% 16O in the 18O-water the I2 is
relatively increased, hence extraction of signal intensity
coming from the I2 peak can contribute to the EIC of
both monoisotopic peptide forms. Interestingly, the EIC
trace calculations became at least as reliable, if not more,
than the two other modes with ratios exceeding the 1:5
level. Otherwise it was observed that the MS and the
MS/MS signals gave a similar level of accuracy on the
ratio, independent of the 18O/16O mixture subjected to
ESI ion trap MS analysis.
As can be seen from Table 1 and Figure 1, the ion
trap MS and MS/MS analysis resulted in rather high
standard deviations for 18O/16O-ratios. It was therefore
interesting to compare directly with results obtained by
LC-MALDI-TOF analysis. The LC-MALDI approach
Table 2. Quantification results on MS and MS/MS data acquired on ESI-IT in comparison with MALDI-TOF (Bruker ReflexIII and
Ultraflex) and MALDI-TOF/TOF (Ultraflex)
18O/16O
expected
MS Instrument and signal
Number
of ionsb
18O/16O
observed
(mean 
SD)
R.D.
(%)
Relative
errorc (%)ESI-IT MALDI-TOFa
5 Precursors 7 4.21  1.18 28.0 16
5 y-Ions 17 4.39  0.50 11.4 12
5 ReflexIII, MS 17 4.76  0.87 18.3 5
5 Ultraflex, MS 13 4.24  0.44 10.4 15
5 Ultraflex, y-ions 42 3.67  1.40 38.1 27
0.2 Precursors 7 0.28  0.15 53.6 29
0.2 y-Ions 20 0.27  0.08 29.6 26
0.2 ReflexIII, MS 13 0.24  0.05 20.8 17
0.2 Ultraflex, MS 15 0.20  0.03 15.0 0
0.2 Ultraflex, y-ions 64 0.29  0.09 31.0 31
aOne chromatographic peak of a RP nanobore LC separation was collected in several MALDI fractions, resulting in an increased number of MS
analyses on the same 18O/16O-labeled peptide pair.
bNumber of ions where the pair of 18O- and 16O-labeled peptides was clearly detected. For ESI precursor ion calculations only the more intense signal
between a 2 or 3 ion signal was included.
cFor relative error calculation, the intensity of the higher abundant isotopic peptide form was divided by the intensity of the less concentrated form.
Table 3. Comparison of 18O/16O-ratio quantification based on 18O/16O peak intensities determined on different mass spectrometers
in MS or MS/MS mode
Peptide
18O/16O
expected
MS instrument
MS signal
Number
of ions
18O/16O observed
(mean  S.D.)
ALELFR 0.5 MALDI-TOF-MS 1 0.41
0.5 ESI-IT, MS 1 0.44
0.5 ESI-QTOF, MS 2 0.49
NWGLSVYADKPETTK 1.0 MALDI-TOF-MS 1 0.91
1.0 ESI-IT, MS 2 0.91
1.0 ESI-QTOF, MS 2 1.01
1.0 MALDI-TOF/TOF-
MS/MS
9 0.87  0.12
1.0 ESI-IT, MS/MS 5 0.90  0.21
1.0 ESI-QTOF, MS/MS 11 0.91  0.19
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allowed for the collection of several fractions from the
same chromatographic peptide peak, hence increasing
the statistics for mean ratio and standard deviation
calculations. However, despite improved statistics and
improved MS resolution on the MALDI-TOF data com-
pared to the ESI-IT data, there was no significant
improvement on the relative error of the calculated
ratios nor on the standard deviations apparent (Table
2). It could be concluded from all these data that relative
quantification with ion trap mass spectrometry of 18O/
16O-labeled peptide ions is feasible and the results are
comparable with MALDI-MS data. Even though the
variability within one data set can be rather high, with
relative standard deviation values in the range of 20–
50%, it should be possible to measure reliably protein
concentration differences as low as 2- to 3-fold with
ESI-QTOF (Figure 2) by combining precursor MS, y-ion
fragment MS/MS, EIC trace and LC-MALDI-MS data.
Application of 18O Exchange to Relative Protein
Quantification in a Human Plasma Subfraction
The availability of quantitative information on protein
expression levels greatly increases the value of protein
identification for a given proteome. We therefore ap-
plied the trypsin-catalyzed 16O-to-18O exchange to a
total trypsin digest of an albumin- and immunoglobu-
lin-depleted human plasma fraction consisting of low
molecular weight proteins (MW cutoff ca. 20 kDa) and
combined it with an equivalent sample prepared in
parallel for 16O labeling. To this mixed plasma sample,
200 pmol 16O-labeled and 100 pmol 18O-labeled pep-
tides of a tryptic digest of horse apomyoglobin were
added as an internal standard. A portion corresponding
to 30% of the total peptide mixture was separated into
17 fractions by strong cation exchange (SCX) chroma-
tography. The peptides collected in fraction 6, eluting
with 50 mM ammonium acetate, were subsequently
analysed by LC-MS/MS using the ESI-IT system with
on-line LC-MALDI fraction collection, as well as with
the ESI-QTOF system as described in the Experimental
Methods section. A database search of the MS/MS data
thus obtained against the SWISS-PROT protein data-
base identified human plasma proteins of low molecu-
lar weight together with the horse apomyoglobin pep-
tide ALELFR. As an example, a peptide with the
sequence NWGLSVYADKPETTK from -1-acid glyco-
protein 1 (A1AG_HUMAN) eluted together with the
horse apomyoglobin peptide and they were subse-
quently sampled on the same MALDI target anchor.
The MALDI-MS is shown in the top panel of Figure 3.
The same peptides were also detected with the ESI-IT as
well as with the ESI-QTOF systems. As can be seen in
Figure 3 the two peptides were present as an 16O/18O-
labeled pair and the 18O/16O-ratios of 0.44 and 0.91
(expected 0.5 and 1.0) calculated from the ion trap MS
and MS/MS peak intensities were confirmed by both
MALDI-TOF and ESI-QTOF MS and MS/MS (Table 3).
It is interesting to note that the illustrated
A1AG_HUMAN peptide is the 3 ion. Although the
isotopic peaks were not completely resolved in the ion
trap mass spectrum, the ratio calculated on the first
isotopic peaks of the 16O- and 18O-labeled isotopic peak
Figure 3. MS analysis with MALDI-TOF and LC-ESI on ion trap
and QTOF of one peptide isolated from a complex, 16O/18O-
labeled protein sample. The low molecular weight protein fraction
(MW cutoff of approximately 20 kDa, 2.28 mg total) of an albumin
and immunoglobulin depleted human plasma sample was di-
gested. The digest was split in two equal portions. Peptides in the
first portion were labeled by trypsin catalyzed 16O-to-16O oxygen
exchange at the C-terminus in normal water, the second portion
by 16O-to-18O oxygen exchange in 18O-water, respectively. The
combined 1:1 mixture was subsequently spiked with a 16O/18O 2:1
mixture of a horse apomyoglobin tryptic digest. One fraction was
analyzed by LC-MS/MS on QTOF and IT coupled with LC-
MALDI. The horse apomyoglobin peptide ALELFR ([M  H] 
748.44), ([M  H]2  374.72) and the peptide NWGLSVYADK-
PETTK ([M  H]  1708.7), ([M  H]3  570.26) from A1AG_
human were identified among others in this particular sample and
eluted at the same time from the column on the ion trap system.
The relatively short apomyoglobin peptide was detected only in
the singly protonated form on the ion trap, but was detected as a
singly and doubly charged ion on the QTOF, whereas the larger
A1AG_HUMAN peptide was detected as a doubly and triply
charged ion on both systems. The top panel is the MALDI-MS
spectrum showing both ions with the insets as a zoom into the
isotopic peak cluster of the two peptide pairs. The middle and the
lower panel show the apomyoglobin and the A1AG_HUMAN
ions as detected on the ion trap and QTOF, respectively. For the
18O/16O-based quantification please refer to Table 3.
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cluster was well within the calculated value from the
time-of-flight measurements. The measured ratios for
the apomyoglobin and the plasma protein peptides
corresponded very well with the values that could be
expected from the experimental setup.
Figure 4 is a representation of another five different
peptides out of four different proteins identified in the
same sample. The first two examples represent the ideal
case. The ESI-generated ions are doubly charged and
the resolution achieved on the ESI-IT is largely suffi-
cient to allow accurate 18O/16O-ratio calculation. Both
examples validate the method, as the experimental ratio
of around 0.90 corresponds well with the theoretically
expected value of 1.0. The APC2 peptide had the
sequence LRDLYSK, the APC3 peptide SEAEDASLLS-
FM(ox)QGYMK. The third example represents a C-
terminal peptide derived from apolipoprotein C3 with
the sequence DKFSEFWDLDPEVRPTSAVAA. As there
is neither a lysine nor an arginine C-terminal residue,
no 18O exchange occured, hence the peptide appears
correctly as a single isotopic cluster. Although such
singular peptide peaks can be used to identify C-
terminal peptides of proteins quickly [21, 24], caution is
required because concentration differences in 16O/18O-
labeled peptides exceeding 20:1 might also be detected
as singlets only.
The last two examples [A1AH peptide of sequence
EQLGEFYEALDC(cam)LC(cam)IPR and IGFA peptide
GPETLC(cam)GAELVDALQFVC(cam)GDR] are cases
where the incorporation of two 18O atoms was less than
complete. The intensity of the third isotopic peak (I2) of
both peptides should theoretically show an intensity
that is between 70–75% of the one of I1. However I2 in
the 16O-labeled peptide isotope cluster is the most
intense peak as detected in both ESI-IT and MALDI-
TOF MS spectra. On the contrary, I6 (the third isotopic
peak in the 18O-labeled peptide) shows only about 50%
of the intensity of I2. As mentioned above, there is
normally little difference between the ratios calculated
by dividing I5 by I1 or I4 by I0 in the case where the
16O-to-18O exchange proceeded quantitatively. This fact
is well demonstrated with example two in Figure 4
(second panel) where the two values differ only by 0.04
for the ESI-IT and 0.09 for the MALDI-TOF spectrum
respectively. Nevertheless there were major differences
between those two ratios in the last two examples of
Figure 4, which were calculated to be 0.61 and 0.86,
respectively. This suggests that the differences between
those ratios could serve as an automatic quality control
over successful oxygen exchange and as a trigger to
initialize accurate calculations using I0, I2, and I4 inten-
sities, as well as natural isotope distributions of pep-
tides as described by Yao and colleagues [13]. It is not
obvious why the oxygen exchange reactions for these
peptides did not reach completion but it had been
shown earlier by Yao et al. [15] and Schno¨lzer et al. [21]
that the kinetics for the oxygen exchange reaction can
differ considerably between different peptides. Coinci-
dently both peptides are rather large and contain two
alkylated cysteine residues. The hydrophobicity and pI
characteristics of both peptides compare well with the
APC3 peptide (second example from top) that showed
complete 16O-to-18O exchange. Immobilized trypsin,
providing high enzyme concentration, should always
be an option when the exchange reaction needs to be
pushed to completion.
Finally, the last example given in Figure 4 (panel 5)
Figure 4. Comparison of ion trap LC-ESI-MS and MALDI-
TOF-MS peak resolution for 18O/16O-ratio calculations. A human
plasma subfraction containing low molecular weight proteins was
digested with trypsin and one half each was enzymatically labeled
with either 16O or 18O, respectively, as described under Experi-
mental Methods and in Figure 3. The peptides of the combined
aliquots were fractionated by cation exchange chromatography
and one particular fraction was subjected to RP chromatography
with on-line ESI-MS/MS on an ion trap and fraction collection for
MALDI-TOF. On the left, the combined MS survey scans of the
precursor ion pairs submitted to MS/MS in the ion trap are shown
together with the corresponding MALDI-MS of the same peptide
precursor ion on the right. At the top of each pair of MS spectra,
the protein identified by means of the ESI-IT MS/MS spectra is
given together with the corresponding 18O/16O-ratio as calculated
by I4/I0 and I5/I1. The charge state of the detected ion on the
ESI-IT MS as well as the m/z values for each of the first monoiso-
topic peak in the 16O/18O peptide pair are marked as well.
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shows a case where the second isotopic peak of the
16O-labeled peptide was disturbed to such an extent that
the peak was not detectable. This is due to the space-
charge effect in the ion trap, an effect that could prevent
the correct ratio calculation for triply and higher charged
peptides on this machine. The space-charge effect is
caused by a heterogenous distribution of energy in cases
where only a few ion species are trapped, resulting in a
perturbation of close ion trajectories, like in the case of
isotopes. The Esquire tries to regulate the trap filling by a
predetermined value (ICC for ion charge control). By
setting this ICC value relatively low, it is rather unlikely to
risk ion trajectory perturbation, hence detecting a mass
shift of the first isotope, due to overloading of the trap
with only one ion species. Therefore analysis of fairly
complex mixtures with a homogenous energy distribution
is an advantage with regards to avoiding space charge
effects. Correspondingly, the samples analyzed so far in
our laboratory by using optimized ESI-IT tuning param-
eters resulted in a rather low occurrence of the space-
charge effect. Furthermore, accurate isotope intensities can
be measured more reliably on doubly charged ions, if
present, where the space charge effect has less impact.
Database Searches
When running an LC-MS/MS experiment where the
mass spectrometer automatically switches from MS to
MS/MS mode by choosing the most intense ions
present in the MS survey scan for fragmentation, it is
obvious that 18O-labeled peptide precursors are sub-
jected to MS/MS. As the precursor mass of such an ion
is 4 Da larger than the naturally occurring peptide mass,
this could prevent a correct identification during the
database search. However, database search algorithms
can account for this by allowing a variable 4 Da
modification at the C-termini.
Ions containing the peptide C-terminus appear as
doublets spaced by 4 mass units in MS/MS spectra.
Others have already exploited this feature of peak
doublets to do peptide de novo sequencing by applying
a 50:50 16O/18O labeling of the C-termini that results in
a mass difference of 2 Da [25, 26]. By recognizing y-ions
this way, we were for instance able to deduce easily the
sequence SVYADQ/K from the MS/MS spectrum ac-
quired on the ESI-QTOF and the ESI-IT of the plasma
peptide shown in Figure 3 with a monoisotopic mass of
1708.5 (Figure 5). A Blast search revealed sequence
alignment with the human -1-glycoprotein 1 protein.
As expected, the N- and C-terminal mass differences of
470.1 and 428.2 fitted exactly to the missing N-terminal
and C-terminal sequences NWGL and PETTK of -1-
glycoprotein 1, respectively. The endoprotease cata-
lyzed 16O-to-18O exchange provides therefore addi-
tional value to a proteome analysis by enabling the
facile confirmation of a database search identification
result in addition to relative quantification data.
Figure 5. Paired 16O/18O peaks of y-ions assist validation of automated sequence identification.
ESI-QTOF and ESI-IT allow the concurrent isolation of both 18O- and 16O-labeled parent ions in the
CID cell. The y-ions bearing the C-terminal labeled Lys or Arg residue appear as paired peaks with
a 4 Da mass difference. The paired ion signals marked with arrows in the QTOF (top) and ion trap
(bottom) MS/MS spectra were readily identified as y-ions and the sequence SVYADQ/K could easily
be assigned. A BLAST search with this sequence tag retrieved sequence similarity to a peptide
sequence of A1AG_HUMAN. Identification of A1AG_HUMAN was confirmed by attributing the
N-terminal mass difference of 470.1 to the NWGL and the C-terminal mass difference of 428.2 to the
PETTK sequences, respectively.
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Conclusions
The trypsin catalyzed 16O-to-18O oxygen exchange
reaction presents a highly specific and versatile
method for the labeling of tryptic peptides with two
stable 18O isotopes, thus increasing the mass of the
labeled peptide by four mass units. The labeling
reaction is generally independent of the amino acid
sequence of the peptide (an exception to this rule is
given in Figure 4) and it is therefore possible to detect
peptides being post-translationally modified. We
show here that the 4 Da mass difference between
labeled and unlabeled peptide is sufficient for the
relative quantification of peptides/proteins using ei-
ther one of the three mass spectrometers tested,
namely ESI-QTOF, ESI-IT, and MALDI-TOF. Despite
the fact that the resolution attainable on an ion trap
mass spectrometer is about four times lower com-
pared to the two TOF instruments, the results pre-
sented here show no obvious difference in measured
16O/18O-ratios. Nevertheless, because of the lower
mass resolution and the space-charge effect with the
ion trap mass detector, problems of accurate isotopic
peak detection can occur, especially with ions
charged 3 and 4.
Although the relative standard deviations of the
calculated mean 16O/18O-ratios were in the order of
20 –50%, it was still possible to distinguish between a
theoretical 1:1 and a 2:1 or 1:2 ratio. A difference of at
least 2- to 3-fold in expressed protein concentrations
between two biological samples is generally accepted
to be of biological significance. A larger cutoff value
such as 5-fold changes can also be applied to focus on
the most important proteins only [27]. The present
approach of conducting comparative proteomics by
means of separating differentially labeled peptide
samples prior to tandem mass spectrometry offers at
least two, and in the case of on-line ESI-MS even
three, possibilities to verify 16O/18O-ratios. The first
and most accurate is by measuring intensities of the
signals generated by the intact peptides in the MS-
survey scans. By averaging all MS scans acquired
over the chromatographic peak of a peptide the S/N
ratio can be increased, hence the accuracy of the ratio
value between the two isotopic forms is improved.
Second, fragmentation of tryptic peptides at low
collision energies or in MALDI-PSD mode produces
usually C-terminal y-ion fragments detected as dou-
blets with a 4 Da mass difference. We show here that,
by tuning the mass spectrometer, both light and
heavy precursor ions are isolated quantitatively for
CID or PSD. Hence, y-ion series can also be used for
relative protein quantification. Yet caution must be
taken in order to avoid using y-ion signals that can be
influenced by underlying signals of a fragment from
the unlabeled N-terminus or an internal fragment.
Programs automatically extracting intensity ratios of
y-ion series directly from MS/MS peak lists, could
use the sequence identified by a database search to
apply a filter removing masses belonging potentially
to N-terminal fragment ions of the b and a series in
order to avoid false ratio calculations. Third, the
chromatographic peaks of EIC traces from the light
and heavy form of a peptide can be integrated to
provide another means of 16O/18O-ratio calculation
based on peak area. It is, however, the least accurate
of the three methods, and it requires substantial raw
data reprocessing based on knowledge of the sample
acquired beforehand with the other two, above men-
tioned methods, and a protein identification. Taken
together, these results suggest that it is possible to
relatively quantify with confidence proteins whose
concentration differ by a factor of two and more.
The direct combination of LC-ESI-MS/MS on an
ion trap or QTOF with parallel fraction deposition of
the RP column eluate on a MALDI target for subse-
quent MALDI-TOF/TOF MS/MS offers many inter-
esting features. First, the two ionization modes pro-
vide complementary data for a potential increase in
protein sequence coverage. Second, the acquisition in
ESI mode on-line to LC separation is prone to miss
out on peptides due to the cycle time of the mass
spectrometer switching from MS to MS/MS mode
and due to the presence of many co-eluting peptides
at a given time. In contrast, once peptides are depos-
ited on a MALDI target they remain amenable to
analysis for a long period of time. Hence, it is
imaginable to do a first survey scan in MS mode
providing a first dataset on 16O/18O-ratios of differ-
entially labeled peptides. In a second MS experiment,
using the tandem MS capability of new generation
MALDI-TOF/TOF instruments, one can perform
MS/MS only on those peptides that showed signifi-
cantly different expression levels in the MS survey
scan, thus saving a lot of machine time. We have
developed, in-house, a peak detection software that
can calculate isotopic ratios of predetermined mass
differentials. The use of such software tools enables
the creation of preferred mass lists for the subsequent
MS/MS experiment spontaneously.
The combined ESI/MALDI approach would ensure
that interesting proteins showing differences in expres-
sion level would not go undetected. This approach is
fast, parallel and only one aliquot of a particular sample
is needed, in contrast to Griffins approach, where a first
aliquot was used to do an MS survey scan on a ESI-TOF
mass spectrometer followed by a second analysis on a
different mass spectrometer doing MS/MS with a pre-
ferred mass list on fractions containing peptides of
interest [28].
The protease-catalyzed 16O-to-18O oxygen exchange
methodology for comparative proteomics relies heavily
on a successful separation of highly complex peptide
mixtures. This is because the total protein content of a
biological sample needs to be digested without presepa-
ration of the intact proteins in order to avoid differential
sample loss due to chromatographic irreproducibility
during the separation of two different samples. We
716 HELLER ET AL. J Am Soc Mass Spectrom 2003, 14, 704–718
have followed the 2-D LC approach to separate very
complex peptide mixtures that was introduced by Yates
and colleagues [29, 30]. Mass spectrometry, especially in
the form of LC-MALDI, adds yet another separation
dimension based on mass.
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